US3930024A
(en)
|
1969-09-02 |
1975-12-30 |
Parke Davis & Co |
Pharmaceutical compositions and methods
|
US3773946A
(en)
|
1969-09-02 |
1973-11-20 |
Parke Davis & Co |
Triglyceride-lowering compositions and methods
|
JPS5522636A
(en)
|
1978-08-04 |
1980-02-18 |
Takeda Chem Ind Ltd |
Thiazoliding derivative
|
WO1980000727A1
(en)
|
1978-09-29 |
1980-04-17 |
Secretary Energy Brit |
Improvements in and relating to electrical power transmission in fluid wells
|
US4469863A
(en)
|
1980-11-12 |
1984-09-04 |
Ts O Paul O P |
Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
|
AU548727B2
(en)
|
1981-03-12 |
1986-01-02 |
Gruppo Lepetit S.P.A. |
Beta-lactam acetic acid derivatives
|
ATE75483T1
(de)
|
1981-10-23 |
1992-05-15 |
Molecular Biosystems Inc |
Oligonukleotides heilmittel und dessen herstellungsverfahren.
|
US5023243A
(en)
|
1981-10-23 |
1991-06-11 |
Molecular Biosystems, Inc. |
Oligonucleotide therapeutic agent and method of making same
|
IL64542A0
(en)
|
1981-12-15 |
1982-03-31 |
Yissum Res Dev Co |
Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
JPS60136512A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
脂質代謝改善剤
|
DE3423166A1
(de)
|
1984-06-22 |
1986-01-02 |
Epis S.A., Zug |
Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
US4722840A
(en)
|
1984-09-12 |
1988-02-02 |
Chiron Corporation |
Hybrid particle immunogens
|
US4709017A
(en)
|
1985-06-07 |
1987-11-24 |
President And Fellows Of Harvard College |
Modified toxic vaccines
|
US5374426A
(en)
|
1986-09-03 |
1994-12-20 |
University Of Saskatchewan |
Rotavirus nucleocapsid protein VP6 in vaccine compositions
|
US4950740A
(en)
|
1987-03-17 |
1990-08-21 |
Cetus Corporation |
Recombinant diphtheria vaccines
|
GB8815795D0
(en)
|
1988-07-02 |
1988-08-10 |
Bkl Extrusions Ltd |
Glazing bead
|
NZ230747A
(en)
|
1988-09-30 |
1992-05-26 |
Bror Morein |
Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
EP0378881B1
(en)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
AU651949B2
(en)
|
1989-07-14 |
1994-08-11 |
American Cyanamid Company |
Cytokine and hormone carriers for conjugate vaccines
|
NZ235315A
(en)
|
1989-09-19 |
1991-09-25 |
Wellcome Found |
Chimaeric hepadnavirus core antigen proteins and their construction
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
JP2999579B2
(ja)
|
1990-07-18 |
2000-01-17 |
武田薬品工業株式会社 |
Dnaおよびその用途
|
IL98715A0
(en)
|
1990-08-13 |
1992-07-15 |
American Cyanamid Co |
Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
|
EP0563091A1
(en)
|
1990-12-20 |
1993-10-06 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Vaccines based on hepatitis b surface antigen
|
DE4202394A1
(de)
|
1991-04-04 |
1992-10-08 |
Teves Gmbh Alfred |
Schwimmsattel-teilbelagscheibenbremse mit einem bremsengehaeuse aus leichtmetall
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
CA2135052A1
(en)
|
1992-05-06 |
1993-11-11 |
R. John Collier |
Diphtheria toxin receptor-binding region
|
ATE156710T1
(de)
|
1992-06-25 |
1997-08-15 |
Smithkline Beecham Biolog |
Adjuvantien enthaltende impfstoffzusammensetzung
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
ATE157882T1
(de)
|
1993-03-23 |
1997-09-15 |
Smithkline Beecham Biolog |
3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
US5917017A
(en)
|
1994-06-08 |
1999-06-29 |
President And Fellows Of Harvard College |
Diphtheria toxin vaccines bearing a mutated R domain
|
US6455673B1
(en)
|
1994-06-08 |
2002-09-24 |
President And Fellows Of Harvard College |
Multi-mutant diphtheria toxin vaccines
|
US6194388B1
(en)
|
1994-07-15 |
2001-02-27 |
The University Of Iowa Research Foundation |
Immunomodulatory oligonucleotides
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
US5648387A
(en)
|
1995-03-24 |
1997-07-15 |
Warner-Lambert Company |
Carboxyalkylethers, formulations, and treatment of vascular diseases
|
EP0817854A2
(en)
|
1995-03-31 |
1998-01-14 |
Wolf, Hans, Prof. Dr. |
Antigen presentation system based on retrovirus-like particles
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
GB9621091D0
(en)
|
1996-10-09 |
1996-11-27 |
Fondation Pour Le Perfectionem |
Attenuated microorganisms strains and their uses
|
JP4111403B2
(ja)
|
1996-10-11 |
2008-07-02 |
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
免疫刺激ポリヌクレオチド/免疫調節分子複合体
|
IL119971A
(en)
|
1997-01-07 |
2003-02-12 |
Yissum Res Dev Co |
Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
|
AUPO517897A0
(en)
|
1997-02-19 |
1997-04-11 |
Csl Limited |
Chelating immunostimulating complexes
|
WO1998037919A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
DK1005368T3
(da)
|
1997-03-10 |
2010-01-04 |
Ottawa Hospital Res Inst |
Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer
|
WO1998052581A1
(en)
|
1997-05-20 |
1998-11-26 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
ATE432348T1
(de)
|
1997-06-06 |
2009-06-15 |
Univ California |
Inhibitoren von immunstimulatorischen dna sequenz aktivität
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
IL121165A0
(en)
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
CA2302554C
(en)
|
1997-09-05 |
2007-04-10 |
Smithkline Beecham Biologicals S.A. |
Oil in water emulsions containing saponins
|
PT1054689E
(pt)
|
1998-02-12 |
2003-11-28 |
Immune Complex Corp |
Proteinas no nucleo da hepatite e estrategicamente modificadas e seus derivados
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
US6218371B1
(en)
|
1998-04-03 |
2001-04-17 |
University Of Iowa Research Foundation |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
KR20010042573A
(ko)
|
1998-04-09 |
2001-05-25 |
장 스테판느 |
애쥬번트 조성물
|
TWI227241B
(en)
*
|
1998-06-20 |
2005-02-01 |
United Biomedical Inc |
IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
ES2188003T3
(es)
|
1998-09-18 |
2003-06-16 |
Pentapharm Ag |
Inhibidores de la uroquinasa.
|
AU5728099A
(en)
|
1998-09-28 |
2000-05-01 |
Hans Balle Aps |
Lift, preferably for seats on wheelchairs
|
US6203837B1
(en)
|
1998-10-06 |
2001-03-20 |
Xcafe' Llc |
Coffee system
|
CN100558401C
(zh)
|
1998-10-16 |
2009-11-11 |
史密丝克莱恩比彻姆生物有限公司 |
佐剂系统及疫苗
|
EP1123114B1
(en)
|
1998-10-21 |
2005-12-28 |
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Virus-like particles for the induction of autoantibodies
|
JP2002528123A
(ja)
|
1998-11-05 |
2002-09-03 |
パウダージェクト ヴァクシンズ,インコーポレイテッド |
遺伝子免疫のための核酸構築物
|
BR9915771A
(pt)
|
1998-11-30 |
2001-12-26 |
Cytos Biotechnology Ag |
Apresentação molecular ordenada de antìgenos,processo de preparação e utilização
|
DE69940439D1
(de)
|
1998-12-21 |
2009-04-02 |
Medimmune Inc |
Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe
|
KR101170203B1
(ko)
|
1998-12-23 |
2012-07-31 |
아이디 바이오메디칼 코포레이션 |
신규한 스트렙토코커스 항원
|
AUPP807399A0
(en)
|
1999-01-08 |
1999-02-04 |
Csl Limited |
Improved immunogenic lhrh composition and methods relating thereto
|
JP5084984B2
(ja)
|
1999-02-17 |
2012-11-28 |
シーエスエル、リミテッド |
免疫原複合体およびそれに関する方法
|
KR20020000785A
(ko)
*
|
1999-03-19 |
2002-01-05 |
장 스테판느 |
백신
|
IL145712A0
(en)
|
1999-04-01 |
2002-07-25 |
Esperion Therapeutics Inc |
Ether compounds, compositions, and uses thereof
|
JP2002541808A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ, インコーポレイテッド |
ポリサッカリド結合体ワクチンのための組換えトキシンaタンパク質キャリア
|
GB9908533D0
(en)
*
|
1999-04-14 |
1999-06-09 |
Novartis Ag |
Organic compounds
|
EP2322210A1
(en)
|
1999-04-19 |
2011-05-18 |
GlaxoSmithKline Biologicals S.A. |
Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
|
NO309798B1
(no)
*
|
1999-04-30 |
2001-04-02 |
Targovax As |
Peptidblanding, samt farmasoytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
|
PL355163A1
(en)
|
1999-09-24 |
2004-04-05 |
Smithkline Beecham Biologicals S.A. |
Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
|
IL148671A0
(en)
|
1999-09-24 |
2002-09-12 |
Smithkline Beecham Biolog |
Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
|
NZ517928A
(en)
|
1999-09-27 |
2004-09-24 |
Coley Pharm Gmbh |
Methods related to immunostimulatory nucleic acid-induced interferon
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
EP1268530B1
(en)
|
2000-04-07 |
2006-08-16 |
University Of Leeds |
Hepatitis b core antigen fusion proteins
|
WO2001085208A2
(en)
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
CA2413450C
(en)
|
2000-06-20 |
2014-02-18 |
Shire Biochem Inc. |
Streptococcus antigens
|
DE60117978T2
(de)
|
2000-06-22 |
2006-11-02 |
UCB Pharma Ltd., Slough |
Modifizierung des hepatitis b kernantigens
|
EP1304947A1
(en)
|
2000-07-15 |
2003-05-02 |
Lighthouse Display International Limited |
Shelf edge display fittings
|
GB0121171D0
(en)
*
|
2001-08-31 |
2001-10-24 |
Glaxosmithkline Biolog Sa |
Vaccine
|
AUPQ912000A0
(en)
|
2000-07-31 |
2000-08-24 |
Crown In The Right Of The Queensland Department Of Health, The |
Improved virus like particles
|
US20030138769A1
(en)
|
2000-08-16 |
2003-07-24 |
Birkett Ashley J. |
Immunogenic HBc chimer particles having enhanced stability
|
US7320793B2
(en)
*
|
2001-01-19 |
2008-01-22 |
Cytos Biotechnology Ag |
Molecular antigen array
|
US20030035806A1
(en)
|
2001-05-11 |
2003-02-20 |
D'ambra Anello J. |
Novel meningitis conjugate vaccine
|
WO2003102165A2
(en)
|
2002-02-21 |
2003-12-11 |
Apovia, Inc. |
IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE
|
CN1599623B
(zh)
*
|
2001-09-14 |
2011-05-11 |
赛托斯生物技术公司 |
免疫刺激物向病毒样颗粒内的包装:制备方法与用途
|
CA2492823A1
(en)
|
2001-09-14 |
2003-03-27 |
Martin F. Bachmann |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
CA2462857C
(en)
|
2001-10-05 |
2012-01-24 |
Cytos Biotechnology Ag |
Angiotensin peptide-carrier conjugates and uses thereof
|
WO2003054007A2
(en)
|
2001-12-20 |
2003-07-03 |
Shire Biochem Inc. |
Streptococcus antigens
|
GB0209878D0
(en)
|
2002-04-30 |
2002-06-05 |
Glaxosmithkline Biolog Sa |
Vaccine
|
WO2004007538A2
(en)
|
2002-07-17 |
2004-01-22 |
Cytos Biotechnology Ag |
Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
|
GB0219524D0
(en)
*
|
2002-08-21 |
2002-10-02 |
Queen Mary & Westfield College |
Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
|
KR100991679B1
(ko)
|
2002-12-10 |
2010-11-04 |
셀덱스 테라퓨틱스 리미티드 |
안정화 면역원성 HBc 키메라 입자
|
CA2518669C
(en)
|
2003-03-13 |
2014-07-29 |
Glaxosmithkline Biologicals S.A. |
Purification process
|
EP1471152A1
(en)
|
2003-04-25 |
2004-10-27 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Mutations in the human PCSK9 gene associated to hypercholesterolemia
|
EP2484374A1
(en)
|
2004-07-18 |
2012-08-08 |
CSL Limited |
Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
|
WO2006134423A2
(en)
|
2004-07-18 |
2006-12-21 |
Coley Pharmaceutical Group, Ltd. |
Methods and compositions for inducing innate immune responses
|
GB0421083D0
(en)
|
2004-09-22 |
2004-10-27 |
Glaxosmithkline Biolog Sa |
Purification process
|
EP1736538A1
(en)
|
2005-06-21 |
2006-12-27 |
Cytos Biotechnology AG |
Process for the preparative purification of virus-like-particles (VLPs)
|
PT2405002E
(pt)
|
2006-02-15 |
2015-01-05 |
Adiutide Pharmaceuticals Gmbh |
Composições e métodos para formulações de oligonucleotídeos
|
US8187833B2
(en)
*
|
2006-05-08 |
2012-05-29 |
Adaerata Limited Partnership |
Chimeric PCSK9 proteins, cells comprising same, and assays using same
|
US7572618B2
(en)
*
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
US20080166785A1
(en)
|
2006-08-16 |
2008-07-10 |
Monica Sala-Schaeffer |
Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use
|
EP2142217B1
(en)
*
|
2007-03-27 |
2014-11-05 |
Merck Sharp & Dohme Corp. |
Method for detecting autoprocessed, secreted pcsk9
|
EP2137218A2
(en)
*
|
2007-04-13 |
2009-12-30 |
Novartis Ag |
Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9)
|
EA020817B1
(ru)
|
2007-06-26 |
2015-02-27 |
Глаксосмитклайн Байолоджикалс С.А. |
Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
|
JOP20080381B1
(ar)
*
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
BRPI0818765A8
(pt)
*
|
2007-10-26 |
2016-02-10 |
Schering Corp |
Polipeptídeo, anticorpo ou seu fragmento de ligação de antígeno, polinucleotídeo, célula hospedeira, vetor, composição, uso e método para produzir polipeptídeo
|
AU2008339904A1
(en)
*
|
2007-12-20 |
2009-07-02 |
Cytos Biotechnology Ag |
Nerve growth factor conjugates and uses thereof
|
AR070315A1
(es)
*
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
AR070316A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
|
TWI445716B
(zh)
*
|
2008-09-12 |
2014-07-21 |
Rinat Neuroscience Corp |
Pcsk9拮抗劑類
|
AT507604A1
(de)
|
2008-11-19 |
2010-06-15 |
Affiris Forschungs & Entwicklungs Gmbh |
Behandlung von atherosklerose
|
US9501570B2
(en)
|
2014-07-14 |
2016-11-22 |
Verizon Patent And Licensing Inc. |
Dynamic routing system
|
US9719791B2
(en)
|
2014-12-10 |
2017-08-01 |
Mapquest, Inc. |
Computerized systems and methods for providing travel information and/or content to users
|
US10114918B2
(en)
|
2016-01-27 |
2018-10-30 |
Arm Limited |
Physical placement control for an integrated circuit based on state bounds file
|
CN109640757B
(zh)
|
2016-06-23 |
2021-02-09 |
睿谱有限公司 |
用于在饮料上打印的装置与方法
|